A Two-Phase Clinical Study of the Minerva AURORA Ablation System

2015-04-18 12:23:22 | BioPortfolio


The primary objective of this study is to evaluate the use of the Aurora Ablation System in reducing menstrual blood loss at 12 months post-treatment. The occurrence of adverse events will be assessed along with an assessment of the reduction of uterine bleeding as measured by a pictorial blood loss assessment chart (PBLAC) or menstrual diary.

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Menorrhagia Due to Benign Causes


Aurora Endometrial Ablation System


University of Szeged




Minerva Surgical, Inc.

Results (where available)

View Results


Published on BioPortfolio: 2015-04-18T12:23:22-0400

Clinical Trials [983 Associated Clinical Trials listed on BioPortfolio]

Comparison of the Efficiency of Bipolar Energy Versus Monopolar Energy in Endometrial Ablation in Women Having Menorrhagia

Since the development a few years ago of bipolar energy in the surgery by operative hysteroscopy, the hysteroscopic treatment of menorrhagia by endometrial ablation can be achieved either ...

Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia

A randomised study including 236 women referred for essential menorrhagia to five university hospitals in Finland was conducted to compare the cost-effectiveness and the quality of life is...

Ultrasound Guided Percutaneous Microwave Ablation for Benign Breast Lesions

The investigators will perform this study to prospectively analyse the clinical outcome after percutaneous microwave ablation(MWA) of benign breast lesion (BBL) under ultrasound (US) guida...

Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study

The primary objective of this study is to test the hypothesis that a minimum 75% volume radiofrequency ablation of fibroids associated with menorrhagia results in reduction of menstrual bl...

French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue

Single arm, multi-center prospective clinical trial to determine the safety and effectiveness of the AQUABEAM System in the treatment of benign prostatic hyperplasia (BPH) in men 45 to 80 ...

PubMed Articles [10135 Associated PubMed Articles listed on BioPortfolio]

Endometrial cancer after endometrial ablation or resection for menorrhagia.

To assess the incidence of endometrial cancer after endometrial ablation or resection (EA/R) for menorrhagia.

Menorrhagia Outcomes of Minimally Invasive Treatments (MOMITS): A 2 to 5-year follow-up.

We conducted a retrospective postal questionnaire-based study to assess the effectiveness and patient experience of minimally invasive treatments for menorrhagia by performing a two- to five-year foll...

Pain is an Independent Risk Factor for Failed Global Endometrial Ablation.

To determine if pain, as part of an indication for global endometrial ablation, is an independent risk factor for failure.

Percutaneous Image-Guided Treatment of Benign Musculoskeletal Tumors in Children.

Percutaneous ablation of benign musculoskeletal tumors in children has become an area of significant clinical growth over the last decade. With growing research interest, the technologies available an...

The prevalence of occult endometrial cancer in women undergoing hysterectomy for benign indications.

To estimate the frequency of occult endometrial cancer in women undergoing hysterectomy for benign indications.

Medical and Biotech [MESH] Definitions

Neoplasms of the endometrial stroma that sometimes involve the MYOMETRIUM. These tumors contain cells that may closely or remotely resemble the normal stromal cells. Endometrial stromal neoplasms are divided into three categories: (1) benign stromal nodules; (2) low-grade stromal sarcoma, or endolymphatic stromal myosis; and (3) malignant endometrial stromal sarcoma (SARCOMA, ENDOMETRIAL STROMAL).

The extension of endometrial tissue (ENDOMETRIUM) into the MYOMETRIUM. It usually occurs in women in their reproductive years and may result in a diffusely enlarged uterus with ectopic and benign endometrial glands and stroma.

Aurora kinase C is a chromosomal passenger protein that interacts with aurora kinase B in the regulation of MITOSIS. It is found primarily in GERM CELLS in the TESTIS, and may mediate CHROMOSOME SEGREGATION during SPERMATOGENESIS.

Procedures used for the targeted destruction of the mucous membrane lining of the uterine cavity.

Benign proliferation of the ENDOMETRIUM in the UTERUS. Endometrial hyperplasia is classified by its cytology and glandular tissue. There are simple, complex (adenomatous without atypia), and atypical hyperplasia representing also the ascending risk of becoming malignant.

More From BioPortfolio on "A Two-Phase Clinical Study of the Minerva AURORA Ablation System"

Quick Search


Searches Linking to this Trial